Akaal Pharma is a clinical-stage drug discovery and development biopharmaceutical company focused on developing novel drugs for the treatment of inflammatory and immune diseases. Akaal has created a pipeline of new small molecule drugs for the treatment of atopic dermatitis, psoriasis, arthritis, pain, multiple sclerosis (MS) and ulcerative colitis (UC). Akaal Pharma applies its proprietary medicinal chemistry and drug discovery platform coupled with broad and in-depth drug discovery and development expertise of our leadership team. Akaal Pharma has strong portfolio of intellectual property/patents on its internally discovered drug candidates. Several patents have been issued including in the US, Europe, Japan, China, Australia and New Zealand. The remaining patents to be issued in Canada, India and other countries are in the process. Akaal Pharma owns 100% of its intellectual property/patents.
Akaal Pharma has successfully completed multiple Phase-1 (proof of concept)clinical trials of its First-in-Class Topical treatment for atopic dermatitis, psoriasis and arthritis. The Phase-2 clinical trial for the topical treatment of atopic dermatitis and psoriasis are underway. Akaal Pharma will initiate Phase-2 clinical trial for the treatment of arthritis with moderate-to-severe pain in Q3' 2017.
Akaal Pharma's is also developing novel, safer and effective small molecule oral drugs for the treatment of MS, UC and other autoimmune diseases.
Akaal Pharma is developing novel, safer and highly effective drug candidates for the treatment of diseases with significantly large unmet medical need. Akaal Pharma's drug pipeline contains innovative new small molecule drugs for the treatment of atopic dermatitis, psoriasis, arthritis, pain, multiple sclerosis (MS) and ulcerative colitis (UC).
Akaal Pharma's business strategy is to partner its proprietary drug candidates with pharmaceutical and biotech companies for clinical development, manufacturing and commercialization of its novel drugs in exchange for upfront fees, research and development funding, milestone payments and potential royalties on product sales. Please contact Akaal Pharma for further details on various partnering opportunities.